Milk Of Magnesia Original
NDC Package 64725-0649-1
Package Information
Milk Of Magnesia Original is • shake well before use • do not exceed the maximum recommended daily dose in a 24 hour period • dose may be taken once a day preferably at bedtime, in divided doses, or as directed by a doctor • drink a full glass (8 oz) of liquid with each dose adults and children 12 years and older: 2 to 4 tablespoonfuls children 6 to 11 years: 1 to 2 tablespoonfuls children under 6 years: ask a doctor. Marketed by Tya Pharmaceuticals, this product is identified by NDC 64725-0649 and is authorized under FDA application part334.
Identification & Billing
- RxCUI: 253017 - magnesium hydroxide 1200 MG in 15 mL Oral Suspension
- RxCUI: 253017 - magnesium hydroxide 80 MG/ML Oral Suspension
- RxCUI: 253017 - magnesium hydroxide 1200 MG per 15 ML Oral Suspension
- RxCUI: 253017 - milk of magnesia 2400 MG per 30 ML Oral Suspension
- RxCUI: 253017 - milk of magnesia 400 MG per 5 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 64725 - Tya Pharmaceuticals
- 64725-0649 - Milk Of Magnesia Original
- 64725-0649-1 - 16 mL in 1 BOTTLE
- 64725-0649 - Milk Of Magnesia Original
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64725-0649-1 identifies a specific commercial package of 16 ml in 1 bottle of Milk Of Magnesia Original, labeled by Tya Pharmaceuticals. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Tya Pharmaceuticals on January 01, 2000. The current certification is valid through December 31, 2017.
How is this Tya Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64725064901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.